GlassScriptPhysician profile
Yvette M Espiritu
NPI 1689954612
$7,380.53
in general payments reported to CMS, 2019-2025
10 companies · $1,858 in 2025
The $1,858 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $696 · 2022: $1,453 · 2023: $914 · 2024: $2,460 · 2025: $1,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,622 · Food and Beverage: $2,515 · Grant: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,621.69 |
| Food and Beverage | $2,514.89 |
| Grant | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,603.22 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,224.57 | 2021-2025 | Watchman Access System, Watchman Flx, General - Structural Heart |
| Abbott Laboratories | $617.76 | 2021-2025 | Navitor, Epic |
| Medtronic, INC. | $401.37 | 2021-2024 | Corevalve Evolut R |
| Cvrx, INC. | $389.82 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.57 | 2022 | |
| Ethicon US, LLC | $35.68 | 2023 | Vistaseal, Stratafix |
| Pfizer INC. | $25.57 | 2023 | |
| Janssen Pharmaceuticals, INC | $24.85 | 2024 | Xarelto |
| Amgen INC. | $18.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvette Espiritu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.